BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 24726063)

  • 1. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas.
    Ferreira MSV; Crysandt M; Braunschweig T; Jost E; Voss B; Bouillon AS; Knuechel R; Brümmendorf TH; Beier F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463038
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Saito T; Akaike K; Kurisaki-Arakawa A; Toda-Ishii M; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T
    Mol Clin Oncol; 2016 Jan; 4(1):61-64. PubMed ID: 26870359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of TERT aberrations in myxoid liposarcoma: TERT reactivation may play a crucial role in tumorigenesis.
    Kunieda J; Yamashita K; Togashi Y; Baba S; Sakata S; Inamura K; Ae K; Matsumoto S; Machinami R; Kitagawa M; Takeuchi K
    Cancer Sci; 2022 Mar; 113(3):1078-1089. PubMed ID: 34971481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT promoter mutations in soft tissue sarcomas.
    Campanella NC; Penna V; Abrahão-Machado LF; Cruvinel-Carloni A; Ribeiro G; Soares P; Scapulatempo-Neto C; Reis RM
    Int J Biol Markers; 2016 Feb; 31(1):e62-7. PubMed ID: 26391479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors.
    Dubbink HJ; Bakels H; Post E; Zwarthoff EC; Verdijk RM
    J Neurooncol; 2014 Nov; 120(2):267-72. PubMed ID: 25035100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Griewank KG; Schilling B; Murali R; Bielefeld N; Schwamborn M; Sucker A; Zimmer L; Hillen U; Schaller J; Brenn T; Schadendorf D; Mentzel T
    Mod Pathol; 2014 Apr; 27(4):502-8. PubMed ID: 24030750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms.
    Reuss DE; Habel A; Hagenlocher C; Mucha J; Ackermann U; Tessmer C; Meyer J; Capper D; Moldenhauer G; Mautner V; Frappart PO; Schittenhelm J; Hartmann C; Hagel C; Katenkamp K; Petersen I; Mechtersheimer G; von Deimling A
    Acta Neuropathol; 2014 Apr; 127(4):565-72. PubMed ID: 24464231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance.
    Momose T; Yoshimura Y; Harumiya S; Isobe K; Kito M; Fukushima M; Kato H; Nakayama J
    Hum Pathol; 2016 Apr; 50():15-23. PubMed ID: 26997434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
    Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
    Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.
    Braig D; Becherer C; Bickert C; Braig M; Claus R; Eisenhardt AE; Heinz J; Scholber J; Herget GW; Bronsert P; Fricke A; Follo M; Stark GB; Bannasch H; Eisenhardt SU
    Int J Cancer; 2019 Aug; 145(4):1148-1161. PubMed ID: 30779112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
    Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
    Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
    Oda Y; Schneider-Stock R; Ryś J; Gruchała A; Niezabitowski A; Roessner A
    Diagn Mol Pathol; 1996 Jun; 5(2):98-106. PubMed ID: 8727096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
    Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
    Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
    Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Bäckdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
    Endocr Relat Cancer; 2014 Jun; 21(3):427-34. PubMed ID: 24803525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spindle cell liposarcoma with a TRIO-TERT fusion transcript.
    Suster DI; Deshpande V; Chebib I; Taylor MS; Mullen J; Bredella MA; Nielsen GP
    Virchows Arch; 2019 Sep; 475(3):391-394. PubMed ID: 30793229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors.
    Sugita S; Aoyama T; Kondo K; Keira Y; Ogino J; Nakanishi K; Kaya M; Emori M; Tsukahara T; Nakajima H; Takagi M; Hasegawa T
    Hum Pathol; 2014 Aug; 45(8):1588-96. PubMed ID: 24856853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
    Rekhi B; Vogel U
    APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
    Cevik D; Yildiz G; Ozturk M
    World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.